Bemotrizinol Receives US FDA Approval
Joint Exclusive Rights Secured for 18 Months
Expansion of Supply to the US Sunscreen Market
Global chemical company BASF announced on the 11th that it will begin full-scale supply of its UV protection ingredient ‘Tinosorb S’ to the US market, following the approval of Bemotrizinol by the United States Food and Drug Administration (FDA).
BASF CI.
BASF has secured rights to sell and market Bemotrizinol in the United States through an additional license agreement signed with DSM Nutritional Products. During the 18-month exclusivity period granted by the FDA, the two companies will hold joint exclusive rights for the sale and marketing of Bemotrizinol. These rights apply to sunscreen products that are manufactured in the United States or imported into the country.
Tinosorb S is BASF’s UV protection product made with Bemotrizinol as its main ingredient and is a broad-spectrum UV filter that blocks both UVA and UVB rays. With its high photostability, it enhances the stability of other UV filters and can be used to develop long-lasting sun protection products.
In addition to Tinosorb S, BASF supplies a range of UV protection ingredients such as Tinosorb, Uvinul, and Z-Cote, as well as raw materials for sun care products including skin conditioning agents, emulsifiers, and viscosity modifiers.
Hot Picks Today
“There’s Good Reason for Samsung’s 600,000 Won Target Price… Stock Surges on Expectations of At Least Tenfold Increase in Shareholder Returns”
With this FDA approval, BASF plans to expand the supply of Tinosorb S to US sunscreen manufacturers, brand owners, and formulation developers.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.